Cardlytics (CDLX) Tops Q3 EPS by 42c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.15), $0.42 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $67.06 million versus the consensus estimate of $57.71 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield